Skip to main content

Table 1 HCV testing volume variation before and after implementation of screening and infection rates at participating centers

From: Emergency department contribution to HCV elimination in the Iberian Peninsula

Hospital, city, country (period analyzed)

Number of tests/month at baseline, before the intervention (mean)*

Number of tests after the intervention (total)

Number of tests/month after the intervention (mean)

Increase in testing (%)

HCV Ab seroprevalence rate (%)

HCV RNA active infection rate (%)

Hospital Dr. José de Almeida, Cascais, Portugal (Sept 2018–Sep 2021)

27.6

38,357

1065

3759

1.5

0.56

Hospital Dr. Nélio Mendonça, Funchal, Portugal (Aug 2020–Jan 2022)

34.7

20,954

1164

3354

0.5

0.17

Hospital Universitari Vall d’Hebron, Barcelona, Spain (Feb 2020–Feb 2022)

6.0

17,560

732

12,100

3.9

0.73

Hospital Universitario Torrecárdenas, Almería, Spain (Aug 2021–Apr 2023)

15.5

12,651

633

3984

1.7

0.35

  1. *The monthly average of individuals tested within the previous 12 months prior to intervention implementation was calculated; in centers where screening was performed for less than 12 months before the intervention, a monthly average of individuals tested was calculated for the available months
  2. HCV Ab hepatitis C virus antibody, HCV RNA hepatitis C virus ribonucleic acid